Jereczek Barbara Alicja

Associate Professor
SSD
MED/36 - IMAGING AND RADIOTHERAPY
Competition sector
06/I1 - IMAGING, RADIOTHERAPY AND NEURORADIOLOGY

Contacts

Workplace

Via Ripamonti, 435 - IEO - Istituto Europeo di Oncologia
20141 MILANO (MI)

Additional phone numbers
0257489037
University email address
Teaching - Programme courses

Postgraduate programmes

A.Y. 2021/2022
2nd level vocational master
A.Y. 2020/2021
1st level vocational master
2nd level vocational master
A.Y. 2019/2020
2nd level vocational master
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
A.Y. 2018/2019
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
Research

Publications

Publications
  • Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial / R. Orecchia, U. Veronesi, P. Maisonneuve, V.E. Galimberti, R. Lazzari, P. Veronesi, B.A. Jereczek-Fossa, F. Cattani, C. Sangalli, A. Luini, P. Caldarella, M. Venturino, D. Sances, S. Zurrida, G. Viale, M.C. Leonardi, M. Intra. - In: THE LANCET ONCOLOGY. - ISSN 1470-2045. - 22:5(2021 May), pp. 597-608.
  • Mastectomy alone for pT1-2 pN0-1 breast cancer patients: when postmastectomy radiotherapy is indicated / M.C. Leonardi, I.R. Scognamiglio, P. Maisonneuve, S. Dicuonzo, D.P. Rojas, M.A. Zerella, A. Morra, M.A. Gerardi, M. Zaffaroni, A. De Scalzi, A. Girardi, F. Magnoni, E. Montagna, C.I. Fodor, V.E. Galimberti, P. Veronesi, R. Orecchia, R. Pacelli, B.A. Jereczek-Fossa, G. Corso. - In: BREAST CANCER RESEARCH AND TREATMENT. - ISSN 0167-6806. - (2021 Apr 27). [Epub ahead of print]
  • Beyond first-line immunotherapy: Potential therapeutic strategies based on different pattern progressions: Oligo and systemic progression / A. Prelaj, C.C. Pircher, G. Massa, V. Martelli, G. Corrao, G.L. Russo, C. Proto, R. Ferrara, G. Galli, A. De Toma, C. Genova, B.A. Jereczek-Fossa, F. de Braud, M.C. Garassino, S.E. Rebuzzi. - In: CANCERS. - ISSN 2072-6694. - 13:6(2021 Mar 15), pp. 1300.1-1300.22.
  • MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218) / S.G. Gugliandolo, M. Pepa, L.J. Isaksson, G. Marvaso, S. Raimondi, F. Botta, S. Gandini, D. Ciardo, S. Volpe, G. Riva, D.P. Rojas, D. Zerini, P. Pricolo, S. Alessi, G. Petralia, P.E. Summers, F.A. Mistretta, S. Luzzago, F. Cattani, O. De Cobelli, E. Cassano, M. Cremonesi, M. Bellomi, R. Orecchia, B.A. Jereczek-Fossa. - In: EUROPEAN RADIOLOGY. - ISSN 0938-7994. - 31:2(2021 Feb), pp. 716-728.
  • Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients / S. Dicuonzo, M.C. Leonardi, S. Raimondi, G. Corrao, V. Bagnardi, M.A. Gerardi, A. Morra, M.A. Zerella, M. Zaffaroni, F. Pansini, F. Cattani, R. Luraschi, C. Fodor, P. Veronesi, R. Orecchia, D.P. Rojas, B.A. Jereczek-Fossa. - In: CLINICAL & TRANSLATIONAL ONCOLOGY. - ISSN 1699-048X. - (2021). [Epub ahead of print] [10.1007/s12094-020-02538-w]